Understanding the Category B Recommendation for Serogroup B Meningococcal Vaccine.

نویسندگان

  • Gary S Marshall
  • Litjen Tan
چکیده

Published recommendations of the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention, which carry the approval of the Secretary of Health and Human Services, provide guidance on how licensed vaccines should be used. Professional organizations such as the American Academy of Family Physicians and the American Academy of Pediatrics (AAP) also develop immunization recommendations. Since 1995, the recommendations of the ACIP, the American Academy of Family Physicians, and the AAP have been harmonized, although minor differences have surfaced from time to time. In the end, some vaccines are recommended for universal use and some are not, despite approval from the US Food and Drug Administration and commercial availability.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older.

This policy statement provides recommendations for the prevention of serogroup B meningococcal disease through the use of 2 newly licensed serogroup B meningococcal vaccines: MenB-FHbp (Trumenba; Wyeth Pharmaceuticals, a subsidiary of Pfizer, Philadelphia, PA) and MenB-4C (Bexsero; Novartis Vaccines, Siena, Italy). Both vaccines are approved for use in persons 10 through 25 years of age. MenB-F...

متن کامل

The Need to Optimize Adolescent Immunization.

The adolescent period heralds the pediatric patient's transition into adulthood. It is a time of dynamic development during which effective preventive care measures can promote safe behaviors and the development of lifelong health habits. One of the foundations of preventive adolescent health care is timely vaccination, and every visit can be viewed as an opportunity to update and complete an a...

متن کامل

Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016

Two serogroup B meningococcal (MenB) vaccines are currently licensed for use in persons aged 10-25 years in the United States. The two vaccines are MenB-FHbp (Trumenba, Pfizer, Inc.) (1) and MenB-4C (Bexsero, GlaxoSmithKline Biologicals, Inc.) (2). In February 2015, the Advisory Committee on Immunization Practices (ACIP) recommended use of MenB vaccines among certain groups of persons aged ≥10 ...

متن کامل

Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016

In response to a university-based serogroup B meningococcal disease outbreak, the serogroup B meningococcal vaccine Trumenba was recommended for students, a rare instance in which a specific vaccine brand was recommended. This outbreak highlights the challenges of using molecular and immunologic data to inform real-time response.

متن کامل

651Epidemiology of Serogroup B Meningococcal Outbreaks and Interim Guidelines for the Use of an Unlicensed Serogroup B Vaccine Under a CDC-Sponsored IND for the Control of Outbreaks in Organizational Settings

651. Epidemiology of Serogroup B Meningococcal Outbreaks and Interim Guidelines for the Use of an Unlicensed Serogroup B Vaccine Under a CDCSponsored IND for the Control of Outbreaks in Organizational Settings Sarah Meyer, MD, MPH; Jessica Macneil, MPH; Amy Blain, MPH; Thomas a. Clark, MD, MPH; Amanda Cohn, MD; For the Meningococcal Outbreak Work Group,; Meningitis and Vaccine Preventable Disea...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Pediatrics

دوره 139 5  شماره 

صفحات  -

تاریخ انتشار 2017